Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Romanian Journal of Internal Medicine
Volume 59 (2021): Issue 3 (September 2021)
Open Access
Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis
Denisa-Corina Ciuculete
Denisa-Corina Ciuculete
University Hospital Colentina
Bucharest, Romania
“Carol Davila” University of Medicine
Bucharest, Romania
CDPC Research Department, Colentina Clinical Hospital
Bucharest, Romania
Search for this author on
Sciendo
|
Google Scholar
Ciuculete, Denisa-Corina
,
Raluca Alexandra Popescu
Raluca Alexandra Popescu
University Hospital Colentina
Bucharest, Romania
“Carol Davila” University of Medicine
Bucharest, Romania
Search for this author on
Sciendo
|
Google Scholar
Popescu, Raluca Alexandra
and
Gheorghe-Andrei Dan
Gheorghe-Andrei Dan
University Hospital Colentina
Bucharest, Romania
“Carol Davila” University of Medicine
Bucharest, Romania
CDPC Research Department, Colentina Clinical Hospital
Bucharest, Romania
Search for this author on
Sciendo
|
Google Scholar
Dan, Gheorghe-Andrei
Aug 26, 2021
Romanian Journal of Internal Medicine
Volume 59 (2021): Issue 3 (September 2021)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Published Online:
Aug 26, 2021
Page range:
270 - 277
Received:
Mar 13, 2021
DOI:
https://doi.org/10.2478/rjim-2021-0015
Keywords
ibrutinib
,
atrial fibrillation
,
anticoagulation
,
thromboembolic prophylaxis
,
haemorrhagic risk
© 2021 Denisa-Corina Ciuculete et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
